Abstract: Genetic studies of autism spectrum disorder (ASD) have revealed a complex, heterogeneous architecture, in which the contribution of rare inherited variation remains relatively un-explored. We performed whole-genome sequencing (WGS) in 2,308 individuals from families containing multiple affected children, including analysis of single nucleotide variants (SNV) and structural variants (SV). We identified 16 new ASD-risk genes, including many supported by inherited variation, and provide statistical support for 69 genes in total, including previously implicated genes. These risk genes are enriched in pathways involving negative regulation of synaptic transmission and organelle organization. We identify a significant protein-protein interaction (PPI) network seeded by inherited, predicted damaging variants disrupting highly constrained genes, including members of the BAF complex and established ASD risk genes. Analysis of WGS also identified SVs effecting non-coding regulatory regions in developing human brain, implicating NR3C2 and a recurrent 2.5Kb deletion within the promoter of DLG2. These data lend support to studying multiplex families for identifying inherited risk for ASD. We provide these data through the Hartwell Autism Research and Technology Initiative (iHART), an open access cloud-computing repository for ASD genetics research.
! 3! 9)
. Considerable progress in gene discovery has come from studies in families with only one affected child (simplex families) identifying de novo (DN) copy number variants (CNV) (10) (11) (12) (13) and de novo frameshift, splice-acceptor, splice-donor, or nonsense variants (collectively referred to as protein-truncating variants (PTVs))(14-18) that increase ASDrisk and account for an estimated 3-5% of ASD cases (7, 8, (19) (20) (21) . Despite having identified roughly 90 ASD-risk genes with high confidence (22, 23) , it is estimated that between 260 and 1,250 genes confer risk for developing ASD(24), leaving substantial room for gene discovery, especially with regards to inherited variation. To date, several recurrent CNVs have also been associated with increased ASD risk(25-27). Evidence for inherited risk variants has been drawn primarily from families containing only one affected child (18, 28) , which are depleted for inherited risk as compared to families with two or more affected children (multiplex families) (10, 24, 29) . Here we used WGS to study the coding and non-coding regions of the genome in the largest cohort of multiplex families evaluated to date to identify de novo and inherited genetic risk factors for ASD.
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Results
WGS was performed to an average depth of 35.9 ± 5.0 ( Fig. S1 ; Methods) in 2,308 individuals (n=493 families) from the Autism Genetic Resource Exchange (AGRE); purified DNA was sequenced from whole blood (n=285) or lymphoblastoid cell line (LCL) DNA (n=2,023) when whole blood DNA was not available. Our cohort consists of families with two or more children diagnosed with ASD and excludes families with known genetic causes or syndromes (Methods ; Table S1, Table S2 ). Single nucleotide variants (SNV) and indels were identified following GATK's best practices(30) ! 4! (Methods) and structural variants (SV) were identified using a combination of BreakDancer(31), GenomeSTRiP(32, 33), LUMPY(34), and Somatic MUtation FINder (SMuFin)(35) (Methods; Fig. 1, Fig. S2 ). We adapted SMuFin for family-based structural variant detection by performing de novo alignment of child reads to the parental reads (Fig. S2c) to provide high sensitivity and break point accuracy in the detection of SVs (Methods). After quality control (Methods), we categorized the inheritance of each variant in the children (e.g., de novo, paternally inherited, unknown phase) and annotated variant/gene properties to facilitate downstream analyses ( Fig. 1) .
Inherited coding and promoter-disrupting variants highlight a syndromic form of ASD and a novel deletion associated with ASD
Since multiplex ASD families are expected to be enriched for inherited risk variants (10, 24, 29), we first assessed rare (allele frequency (AF) !0.1%) inherited variants, finding no excess of rare inherited missense or PTV variants in affected subjects (Fig. 2a, Fig.   S3 ). Based on previous analyses(28), we asked if there was an enrichment of inherited private PTVs in loss-of-function intolerant genes (pLI"0.9)(36) and found no significant excess in affected subjects (P=0.40, quasi-Poisson linear regression, Fig. S4a ). We also observed no difference in the overall rate of rare inherited SVs between affected and unaffected individuals, even when restricting to gene-disrupting SVs (Fig. S4c-h ).
We next identified rare, damaging variants in loss-of-function intolerant genes (pLI"0.9)(36) transmitted to all affected individuals of a multiplex family, but not to the unaffected individuals (Methods). A total of 62 PTVs and 40 SVs disrupting a coding ! 5! exon or promoter were identified in 98 unique genes; including three genes, NR3C2, NRXN1, and ZMYM2, disrupted by both a PTV in one family and an SV in a second family. For example, the NR3C2 gene harbors a rare PTV and a ~850bp deletion (chr4:
149363005 -149363852) in the promoter region of NR3C2 that are transmitted to both affected children in each family (Fig. 2c) . The deleted promoter region of NR3C2 falls in a functional non-coding regulatory region in developing human brain(37) (chr4:149362706-149367485) (Fig. 2c) . Expanding to include PolyPhen-2 damaging missense variants in NR3C2, we identify a third family with a rare missense variant transmitted from father to both affected children (Fig. 2c) . The three families identified with a transmitted regulatory or protein-disrupting variant in NR3C2 share striking phenotypic similarities, defining a new syndromic form of ASD characterized by metacarpal hypoplasia, high arched palate, sensory hypersensitivity, and abnormal prosody (Table S3) .
Additionally, three families carry the same 2.5Kb deletion in the promoter region of DLG2 (chr11: 85339733 -85342186); a gene that is associated with cognition and learning in mice and humans(38, 39) (Fig. S4b) . This deletion falls in a previouslydefined functional non-coding regulatory region in developing human brain(37) (chr11: 85338026 -85340560) (Fig. S4b) and occurs on a different haplotype in each of the three families (Methods , Table S4 ). No deletions were observed to overlap the identified DLG2 promoter deletion in public databases or any controls (n = 26,353 controls, 
Methods
Genes hit by high-risk inherited variants show biological convergence
We next determined whether the 98 genes harboring PTVs and SVs transmitted to all affected individuals represented a random or broadly acting collection of genes, or had evidence for biological convergence, reasoning that the latter would provide orthogonal support. Indeed, the protein products of these genes formed a significant direct protein-
protein interaction (PPI) network (Methods, 1000 permutations, P < 0.008; Fig. 2d ). genes. This indirect interaction network was also significant (P < 0.002) and seven proteins in this network were found to be significantly connected hubs (corrected seed score P < 0.05) (Fig. 2d) . Gene set enrichment (Methods) identified slight enrichment for targets of RBFOX1(44) (P=0.034, uncorrected), which regulates neuronal alternative splicing and previously has been implicated in ASD (10, 45) .
Identification of high-quality de novo variants by machine learning
De novo missense and PTVs have been identified as significant risk factors for ASD in simplex families (17, 18, 46 (Fig. S5) . The resulting random forest classifier achieved an area under the receiver operating characteristic (ROC) curve of 0.99 and 0.98 in the training and test set, respectively (Fig. 3a, 3b ). We selected a conservative ARC score threshold (0.4) that achieved a minimum precision and recall rate of >0.9 and ~0.8, respectively, across all 10-folds of the training set cross validation (Fig. S7c, S7d) ; and achieved a precision and recall rate of >0.9 and >0.8, respectively, in the test set (Fig. S7h) .
We applied ARC to all raw RDNVs identified in the 1,177 children for whom both biological parents were also sequenced (fully phase-able samples) from 422 iHART families, observing that ARC eliminated many more raw RDNVs in LCL samples than in WB samples ( (Fig. 3e) Fig. S10 ). However, we also failed to replicate 13 of the genes previously published with an FDR<0.1(22) (Fig. S10) .
The q-values for these 13 genes were borderline significant in iHART ( 
Candidate genes harboring high-risk inherited variation form a significant network
We then asked if the proteins encoded by the 98 candidate genes harboring PTVs and SVs transmitted to all affected individuals interact with the 69 ASD-risk genes identified in the TADA mega-analysis (FDR<0.1). The resulting PPI network formed by these 165
unique genes is significant for the direct edges count (P=0.036), the seed direct degrees mean (P=0.046), and the CI degrees mean (P=0.005) (Fig. 5a, Fig. S11c ). This network reveals interactions between genes with different levels of statistical support, ranging from high-risk inherited candidate genes, established ASD risk genes, and new ASD-risk genes, which provides evidence that at least some of these 98 candidate genes are true ASD risk genes.
Given that a large number of predicted ASD-risk genes remain unidentified(24), we next applied NetSig(62), a newly developed method that identifies high probability candidate genes by integrating PPI and association statistics. We identified 596 genes that were significantly directly connected to ASD-risk genes (Methods; 
Discussion
To date, de novo variants have provided compelling evidence for dozens of ASD-risk genes. Here we used WGS to identify more than a dozen new genes that are significantly associated with ASD-risk, the majority of which are due to a contribution from rare inherited mutations. The identification of 16 novel ASD-risk genes was facilitated by exploiting a cohort ascertained for families containing two or more children with ASD where inherited risk variants are likely to contribute to the observed ASD recurrence (10, 24, 29) . We also identified genes (pLI"0.9) harboring inherited damaging variants transmitted to all affected children and not transmitted to any unaffected children that form a PPI network. This PPI network is seeded by known ASD-risk genes and members of the BAF complex, and also enriched for proteins that interact with additional ASD-risk genes, many of which are involved in cortical neurogenesis(42). This is supported by the single cell sequencing data which reveals expression of many of these ASD risk genes in developing glutamatergic neurons (Fig. S12) . Further, the observation that the highconfidence novel ASD-risk genes (FDR<0.1) and additional candidate ASD-risk genes (FDR<0.2) are enriched for inherited variation is logically consistent with the fact that previous ASD studies have primarily focused on simplex ASD families, where de novo variants are known to have a critical contribution to ASD risk.
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We employed WGS to enable the detection of non-coding variants and structural variation at high resolution. We identified one AGRE/iHART family with a likely pathogenic SNV in the NR3C2 gene and a second family with a structural variant (deletion) disrupting the promoter region for this gene. The shared phenotypic features amongst the variant carriers is consistent with a new syndromic form of ASD (Table S3) .
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